What is the market doing?
What the tape says about INSM
Insmed Incorporated is +14% over the past year while the S&P 500 is +23%: 8.8 points behind the market.
+14%
1-year return · S&P 500 +23%
- vs 200-day average
- −16%
vs 200-day average · a clear downtrend
- RSI (14)
- 37
RSI (14) · neutral
- Below its 52-week high
- −41%
Below its 52-week high
Details›
- Last close2026-08-26
- $124.36
- 1 monthS&P 500 +3.7%
- +16%
- 1 yearS&P 500 +23%
- +14%
- 5 yearsS&P 500 +87%
- +415%
- vs 50-day average$110.42
- +13%
- 52-week high
- $211.41
- 52-week low
- $91.88
- Annualised volatility
- 56%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$9.7M
| Year | Return |
|---|---|
| 2026 (year to date) | −29% |
| 2025 | +152% |
| 2024 | +123% |
| 2023 | +55% |
| 2022 | −27% |
| 2021 | −18% |
| 2020 | +39% |
| 2019 | +82% |
| 2018 | −58% |
| 2017 | +136% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +5.9% |
| Feb | 10 | 5 of 10 | +4.3% |
| Mar | 10 | 2 of 10 | −5.7% |
| Apr | 10 | 5 of 10 | +3.7% |
| May | 10 | 3 of 10 | +3.7% |
| Jun | 10 | 8 of 10 | +11% |
| Jul | 11 | 6 of 11 | +1.3% |
| Aug | 11 | 7 of 11 | +2.6% |
| Sep | 10 | 7 of 10 | +19% |
| Oct | 10 | 4 of 10 | −3.1% |
| Nov | 10 | 8 of 10 | +10% |
| Dec | 10 | 3 of 10 | −3.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
Ranks #140 of 145 by Smart Score